Literature DB >> 16999936

APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot traffic.

Ryan P Bennett1, Elie Diner, Mark P Sowden, Joshua A Lees, Joseph E Wedekind, Harold C Smith.   

Abstract

Human APOBEC3G (hA3G) is a member of the APOBEC-1 related protein (ARP) family of cytidine deaminases. hA3G functions as a natural defense against endogenous retrotransposons and a multitude of retroviruses, most notably human immunodeficiency virus type 1 (HIV-1). Nothing is known about the cellular function of hA3G, however, upon HIV-1 infection hA3G functions as an antiviral factor by mutating viral single-stranded DNA during reverse transcription. Whereas homologous deaminases such as APOBEC-1 and AID act on RNA and DNA, respectively, in the cell nucleus, hA3G mutagenic activity appears to be restricted to the cytoplasm. We demonstrate that hA3G is not a nucleo-cytoplasmic shuttling protein like APOBEC-1 and AID, but is strongly retained in the cytoplasm through a mechanism that involves both the N and C-terminal regions of the protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16999936      PMCID: PMC1847397          DOI: 10.1016/j.bbrc.2006.09.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

1.  A short amino acid sequence able to specify nuclear location.

Authors:  D Kalderon; B L Roberts; W D Richardson; A E Smith
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

Review 2.  Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue.

Authors:  N O Davidson
Journal:  Ann Med       Date:  1993-12       Impact factor: 4.709

3.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.

Authors:  L M Powell; S C Wallis; R J Pease; Y H Edwards; T J Knott; J Scott
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

4.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

Authors:  S H Chen; G Habib; C Y Yang; Z W Gu; B R Lee; S A Weng; S R Silberman; S J Cai; J P Deslypere; M Rosseneu
Journal:  Science       Date:  1987-10-16       Impact factor: 47.728

5.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.

Authors:  S Yamanaka; M E Balestra; L D Ferrell; J Fan; K S Arnold; S Taylor; J M Taylor; T L Innerarity
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

6.  Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation.

Authors:  Pablo Oppezzo; Françoise Vuillier; Yuri Vasconcelos; Gérard Dumas; Christian Magnac; Beatrice Payelle-Brogard; Otto Pritsch; Guillaume Dighiero
Journal:  Blood       Date:  2003-01-09       Impact factor: 22.113

Review 7.  Apolipoprotein B mRNA editing: the sequence to the event.

Authors:  H C Smith
Journal:  Semin Cell Biol       Date:  1993-08

8.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.

Authors:  Bastien Mangeat; Priscilla Turelli; Gersende Caron; Marc Friedli; Luc Perrin; Didier Trono
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

9.  A nuclear localization domain in the hnRNP A1 protein.

Authors:  H Siomi; G Dreyfuss
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

10.  Constitutive expression of AID leads to tumorigenesis.

Authors:  Il-mi Okazaki; Hiroshi Hiai; Naoki Kakazu; Shuichi Yamada; Masamichi Muramatsu; Kazuo Kinoshita; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  19 in total

1.  Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.

Authors:  Mark D Stenglein; Hiroshi Matsuo; Reuben S Harris
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

2.  Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

Authors:  Allison M Land; Emily K Law; Michael A Carpenter; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

3.  Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.

Authors:  Harold Oliva; Rodrigo Pacheco; José M Martinez-Navio; Marta Rodríguez-García; Mar Naranjo-Gómez; Núria Climent; Carolina Prado; Cristina Gil; Montserrat Plana; Felipe García; José M Miró; Rafael Franco; Francesc E Borras; Naveenan Navaratnam; José M Gatell; Teresa Gallart
Journal:  Immunol Cell Biol       Date:  2016-03-18       Impact factor: 5.126

4.  The mechanisms regulating the subcellular localization of AID.

Authors:  Anne-Marie Patenaude; Javier M Di Noia
Journal:  Nucleus       Date:  2010-03-31       Impact factor: 4.197

5.  Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?

Authors:  Iris Cadima-Couto; Joao Goncalves
Journal:  Adv Virol       Date:  2010-09-21

6.  C to U editing at position 32 of the anticodon loop precedes tRNA 5' leader removal in trypanosomatids.

Authors:  Kirk W Gaston; Mary Anne T Rubio; Jessica L Spears; Irena Pastar; F Nina Papavasiliou; Juan D Alfonzo
Journal:  Nucleic Acids Res       Date:  2007-10-04       Impact factor: 16.971

7.  Commentary on "Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2".

Authors:  F Martignano; S Di Giorgio; G Mattiuz; S G Conticello
Journal:  J Appl Genet       Date:  2022-03-12       Impact factor: 2.653

8.  T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.

Authors:  Beth K Thielen; Kevin C Klein; Lorne W Walker; Mary Rieck; Jane H Buckner; Garrett W Tomblingson; Jaisri R Lingappa
Journal:  PLoS Pathog       Date:  2007-09-21       Impact factor: 6.823

Review 9.  HIV-1 Vif, APOBEC, and intrinsic immunity.

Authors:  Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2008-06-24       Impact factor: 4.602

10.  The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.

Authors:  James H Miller; Vlad Presnyak; Harold C Smith
Journal:  Retrovirology       Date:  2007-11-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.